Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy

Journal of Infectious Diseases

Volumn 183, Issue 9, 2001, Pages 1399-1404

  Jacobson, Mark A ^a   Schrier, Rachel ^a   McCune, Joseph M ^a,b,c   Torriani, Francesca J ^a   Holland, Gary N ^f   O’Donnell, James J ^a   Freeman, William R ^e   Bredt, Barry M ^d  

^a Department of Medicine ^*  (United States)

^b Departments of Microbiology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVORS; TREATMENT OUTCOME;

EID: 0035341531     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319854     Document Type: Article

References (15)

1. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis
2. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy
3. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies
4. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis
5. Long lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
6. Discontinuation of anticytomegalovirus therapy in patients with HIV infections and cytomegalovirus retinitis
7. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy
8. Immune predispositions for cytomegalovirus retinitis in AIDS
9. - T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
10. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
11. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
12. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression
13. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy
14. Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients
15. Evidence that HAART induced immune recovery vitritis in CMV retinitis patients is immune mediated